DanielWCoyneMD

Nephrology • Saint Louis, MO

Professor, Internal Medicine, Washington University School of Medicine

Join to view full profile

Dr. Coyne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Coyne's full profile

Already have an account?

Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110
Phone+1 314-362-7603

Fax+1 314-747-5213

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1987 - 1989
Emory University School of MedicineResidency, Internal Medicine, 1983 - 1986
Case Western Reserve University School of MedicineClass of 1983

Certifications & Licensure

MO State Medical License 1989 - 2026
OH State Medical License 1990 - 1994
GA State Medical License 1984 - 1989
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Nephrology

Clinical Trials

The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients Start of enrollment: 2006 Apr 01
Completed
Phase 1
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) Start of enrollment: 2009 Feb 01
Completed
Phase 4

Publications & Presentations

PubMed

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.
Jeffrey T Ha, Swapnil Hiremath, Min Jun, Suetonia C Green, David C Wheeler
NEJM Evidence. 2024-09-01
Iron Repletion for Patients with Heart Failure and Kidney Dysfunction.
Daniel W Coyne
Clinical Journal of the American Society of Nephrology. 2023-09-01
17 citations
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, N...
Daniel W Coyne, Ajay K Singh, Renato D Lopes, Christine K Bailey, Tara L DiMino
Clinical Journal of the American Society of Nephrology. 2022-09-01

Other

The Value of Intravenous Iron: Beyond the Cave of Speculation
Daniel Coyne, MD, American Society of Nephrology
https://www.doximity.com/articles/b6612a40-619b-4786-9597-ad389c1683b1
UpToDate, Wolters Kluwer Health - 2012-10-24

Press Mentions

Akebia and GSK Will Grapple with Heightened Scrutiny of HIF PHIs After Roxadustat ConcernsAugust 24th, 2021
1A? No Way. KDOQI Has Lost Its WayMay 14th, 2021
Pooled Results of Roxadustat Phase 3 StudiesApril 15th, 2021
Join now to see all

Grant Support

Differential Effects Of Doxercalciferol (HECTORAL) And 19-Nor-1,25 DihydroxyNational Center For Research Resources2005